Chronic mucocutaneous candidiasis, mycobacterial infections and rosacea in a Mexican adult with STAT1 gain of function
Abstract
STAT1 is a cytoplasmic transcription factor associated with cell growth regulation, differentiation, proliferation, metabolism, and apoptosis. IFN-mediated JAK/STAT signaling pathway is involved in eliminating intracellular pathogens and viruses.
However, pathogenic variants in STAT1 can result in impaired or increased function. Increased activity or function in STAT1 was described in 2011 and is characterized by excessive phosphorylation of the transcription factor. Carriers can develop autoimmune and inflammatory diseases and are susceptible to fungal, viral, and bacterial infections. The early and common manifestation is chronic mucocutaneous candidiasis.
Here, we report a clinical case of a patient with increased STAT1 activity or gain of function, which started in the first year of his life. He is currently 27 years old and has presented bacillus Calmette-Guérin and Mycobacterium tuberculosis infection, chronic mucocutaneous candidiasis, tinea capitis, and facial and ocular rosacea. HIV infection was ruled out.
Given the clinical manifestations, an inborn error of immunity was suspected, specifically STAT1 with gain of function. The diagnosis was corroborated by the sequencing of multiple genes associated with inborn errors of immunity. The pathogenic variant c.961A>G (p.Arg321Gly) in the STAT1 gene, previously reported as a gain of function mutation, was found in the patient.
Finally, this case illustrates that mutations in immune-associated genes can contribute to producing severe and recurrent infections, even in adult patients. Chronic mucocutaneous candidiasis should raise suspicion of gain of function in STAT1.
Downloads
References
Hu X, Li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: From bench to clinic. Signal Transduct Target Ther. 2021;6:402. https://doi.org/10.1038/s41392-021-00791-1
Luo Y, Alexander M, Gadina M, O’Shea JJ, Meylan F, Schwartz DM, et al. JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition. J Allergy Clin Immunol. 2021;148:911-25. https://doi.org/10.1016/j.jaci.2021.08.004
Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL. Human STAT1 gain-of-function heterozygous mutations: Chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40:1065-81. https://doi.org/ 10.1007/s10875-020-00847-x
Asano T, Utsumi T, Kagawa R, Karakawa S, Okada S. Inborn errors of immunity with lossand gain-of-function germline mutations in STAT1. Clin Exp Immunol. 2023;212:96-106. https://doi.org/10.1093/cei/uxac106
Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508-20. https://doi.org/10.1007/s10875-022-01352-z
Toubiana J, Okada S, Hiller J, Oleastro M, Lagos-Gómez M, Aldave-Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154-64. https://doi.org/10.1182/blood-2015-11-679902
Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36:73-84. https://doi.org/10.1007/s10875-015-0214-9
Zhang W, Chen X, Gao G, Xing S, Zhou L, Tang X, et al. Clinical relevance of gain- and loss-of-function germline mutations in STAT1: A systematic review. Front Immunol. 2021;12:654406. https://doi.org/10.3389/fimmu.2021.654406
Pedraza-Sánchez S, Méndez-León JI, González Y, Ventura-Ayala ML, Herrera MT, Lezana-Fernández JL, et al. Oral administration of human polyvalent IgG by mouthwash as an adjunctive treatment of chronic oral candidiasis. Front Immunol. 2018;9:2956. https://doi.org/10.3389/fimmu.2018.02956
Luis BAL, Calva-Mercado JJ. Recurrent spontaneous intestinal perforation due to STAT1- GOF mutation. Am J Gastroenterol. 2018;113:1057-8. https://doi.org/10.1038/s41395-018-0089-5
Pedraza-Sánchez S, Lezana-Fernández JL, González Y, Martínez-Robles L, Ventura-Ayala ML, Sadowinski-Pine S, et al. Disseminated tuberculosis and chronic mucocutaneous candidiasis in a patient with a gain-of-function mutation in signal transduction and activator of transcription 1. Front Immunol. 2017;8:1651. https://doi.org/10.3389/fimmu.2017.01651
Staines-Boone AT, Vignesh P, Tsumura M, de la Garza-Fernández G, Tyagi R, Rawat A, et al. Fatal COVID-19 infection in two children with STAT1 gain-of-function. J Clin Immunol. 2023;44:20. https://doi.org/10.1007/s10875-023-01634-0
Saez-de-Ocariz M, Suárez-Gutiérrez M, Migaud M, Farrill-Romanillos PO, Casanova JL, Segura-Méndez NH, et al. Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation. J Eur Acad Dermatol Venereol. 2020;34:e265-7. https://doi.org/10.1111/jdv.16241
Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635-48. https://doi.org/10.1084/jem.20110958
Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36:81-6. https://doi.org/10.1016/j.det.2017.11.001
Ma Y, Wang X, Li R. AIRE gene mutation predisposing chronic mucocutaneous candidiasis and pigmented retinitis in two kids from a Chinese family. Emerg Microbes Infect. 2022;11:1705-6. https://doi.org/10.1080/22221751.2022.2090860
Deyà-Martínez A, Rivière JG, Roxo-Junior P, Ramakers J, Bloomfield M, Guisado HP, et al. Impact of JAK inhibitors in pediatric patients with STAT1 gain-of-function (GOF) mutations—10 children and review of the literature. J Clin Immunol. 2022;42:1071-1082. https://doi.org/10.1007/s10875-022-01257-x
Bloomfield M, Kanderová V, Paračková Z, Vrabcová P, Svatoň M, Froňková E, et al. Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gainof-function mutation. J Clin Immunol. 2018;38:589-601. https://doi.org/10.1007/s10875-018-0519-6
Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht K, et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018;142:1665-9. https://doi.org/10.1016/j.jaci.2018.07.020
Some similar items:
- Nelson José Alvis-Zakzuk, María de los Ángeles Carrasquilla, Verónica Jhajaira Gómez, Jaime Robledo, Nelson Rafael Alvis-Guzmán, José Mauricio Hernández, Diagnostic accuracy of three technologies for the diagnosis of multi-drug resistant tuberculosis , Biomedica: Vol. 37 No. 3 (2017)
- Johana Rueda, Teresa Realpe, Gloria Mejía, Elsa Zapata, Jaime Robledo, GenoType MTBDRplus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis , Biomedica: Vol. 35 No. 4 (2015)
- Claudia Llerena, Raquel Medina, Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia , Biomedica: Vol. 37 No. 1 (2017)
- Andrés F. Zea-Vera, Carlos Andrés Rodríguez, Sebastián Giraldo, Mario Alejandro Chacón, Luis Fernando Guerrero, Dr., Dr., Dr., María Andrea García, María A. Rengifo, Anilza Bonelo, Maximiliano Parra, Infections, autoimmunity and immunodeficiencies are the leading etiologies of non-cystic fibrosis bronchiectasis in adults from the southwest of Colombia. , Biomedica: Vol. 44 No. Sp. 2 (2024): Inmunología clínica
- Juan Gabriel Bueno-Sánchez, Jairo René Martínez-Morales, Elena E. Stashenko, Wellman Ribón, Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia , Biomedica: Vol. 29 No. 1 (2009)
- Amanda Maestre, Jaime Carmona-Fonseca, Amanda Maestre, Alta frecuencia de mutaciones puntuales en pfcrt de Plasmodium falciparum y emergencia de nuevos haplotipos mutantes en Colombia , Biomedica: Vol. 28 No. 4 (2008)
- María Consuelo Garzón, Dailyn Yorledy Angée, Claudia Llerena, Dora Leticia Orjuela, Jorge Ernesto Victoria, Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs , Biomedica: Vol. 28 No. 3 (2008)
- Leandro Galvis, Ángel Y. Sánchez, Leonardo F. Jurado, Martha I. Murcia, Tuberculosis associated with tumor necrosis factor-α antagonists, case description and analysis of reported cases in Colombia , Biomedica: Vol. 38 No. 1 (2018)
- Diego Chaves, Andrea Sandoval, Luis Rodríguez, Juan C. García, Silvia Restrepo, María Mercedes Zambrano, Comparative analysis of six Mycobacterium tuberculosis complex genomes , Biomedica: Vol. 30 No. 1 (2010)
- María Imaz, Sonia Allassia, Mónica Aranibar, Alba Gunia, Susana Poggi, Ana Togneri, Lidia Wolff, Group of Implementation of Fluorescence, Performance of LED fluorescence microscopy for the detection of acid-fast bacilli from respiratory samples in peripheral laboratories in Argentina , Biomedica: Vol. 37 No. 2 (2017)
Copyright (c) 2024 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
